Aiosyn Company
Aiosyn uses artificial intelligence to develop pathology algorithms to improve the precision of diagnostics in cancer and chronic kidney diseases. The company uses a modular SaaS model to integrate its algorithms with existing pathology workflows. At the same time it leverages its algorithms and AI capabilities to improve the efficiency of cancer and CKD drug development studies for biopharma.
Connections from
Technology:
AI-based Diagnostics and Imaging
Founded Date:
2021-07-30 00:00:00
Headquarters:
Nijmegen,Gelderland,The Netherlands,Europe
Funding Status:
private
Industry:
Clinical AI